Bibliography for Item 6 in BGP

Used Resources

• Merck, "Merck Annual Report: 2000," 2000, Last Accessed April 6 2009, http://www.anrpt2000.com/
• Wikipedia, Amgen, http://en.wikipedia.org/wiki/Amgen
• Wikipedia, Genentech, http://en.wikipedia.org/wiki/Genentech
• Wikipedia, Genzyme, http://en.wikipedia.org/wiki/Genzyme
• Wikipedia, Gilead_Sciences, http://en.wikipedia.org/wiki/Gilead_Sciences
• Wikipedia, Biogen_Idec, http://en.wikipedia.org/wiki/Biogen_Idec
• Wikipeida, Cephalon, http://en.wikipedia.org/wiki/Cephalon
• Wikipeida, MedImmune http://en.wikipedia.org/wiki/MedImmune
• Wikipedia, Celgene, http://en.wikipedia.org/wiki/Celgene
• Wikipedia, ImClone_Systems, http://en.wikipedia.org/wiki/ImClone_Systems
• Wikipedia, List of Biotechnology Companies, http://en.wikipedia.org/wiki/List_of_biotechnology_companies
• Bernheim, Malkie and Jessica Disch "Elsevier Partners With Communispace to Launch Global Online Community", Fox Business, Wednesday, March 25, 2009. Last Accessed: March 29, 2009 Available at: http://www.foxbusiness.com/story/markets/industries/media/elsevier-partners-communispace-launch-global-online-community/
• 2collab, Elsevier B.V., 2009. Available at: http://www.2collab.com/
• "What is 2collab?", Elsevier B.V., 2009. Available at: http://www.2collab.com/about
• "FAQ", Elsevier B.V., 2009. Available at: http://www.2collab.com/faq
• Smith, Laura, "Elsevier Dips Toe in Web 2.0 Water," Information World Review, November 2007
• "Elsevier Sponsors a More Open Access Journal Model", Information World Review, July/August 2006
• Albanese, Andrew, "Elsevier Tries Open Access Option," Library Journal, July, 2006. pp. 22
• "PMC Back Issue Digitization Project", PubMed Central, February 2, 2008. Last Accessed MArch 29 2009. Available at: http://www.pubmedcentral.nih.gov/about/scanning.html
• "Facts and Figures", Verlagsgruppe Georg von Holtzbrinck, Last Accessed March 29 2009. Available at: http://www.holtzbrinck.com/artikel/778437&s=en
• "Nature Biotechnology", Wikipedia, Last Accessed March 29 2009. Available at: http://en.wikipedia.org/wiki/Nature_Biotechnology.
• "Policy statement: Nature Publishing Group to publish genomes using Creative Commons licence," Nature Publishing Group, December 2007. Available at: http://www.nature.com/press_releases/policystatement_pr.pdf
• Baynes, Grace, "InnoCentive and Nature Publishing Group announce partnership to facilitate open innovation," Nature Publishing Group, March 20 2009. Last Accessed March 29 2009. Available at: http://www.nature.com/press_releases/innocentive.html
• Questi, Terra "Scientists Get a 2nd Life," ScienceNews, March 24 2008. Last Accessed March 29 2009. Available at: http://www.sciencenews.org/view/feature/id/31953/title/Scientists_Get_a_2nd_Life.
• Smith, Laura, "Developing nations get free journal access from Nature" Information World Review, April 23 2008, Last Accessed March 29 2009. Available at: http://www.iwr.co.uk/information-world-review/news/2214951/developing-nations-free-journal
• "Connotea," Nature Publishing Group, 2009. Last Accessed March 29 2009. Available at: http://www.connotea.org/
• Thomas, Kim, "Nature injects Sermo buttons," Information World Review, February 4 2008, Last accessed: March 29 2009. Available at: http://www.iwr.co.uk/information-world-review/news/2208994/nature-injects-sermo-buttons-3779408
• Musgrove, Mike, "Into Facebook and Old Friends" Washington Post, September 30 2007, Last accessed March 29 2009. Available at: http://www.iwr.co.uk/information-world-review/news/2208994/nature-injects-sermo-buttons-3779408
• "Foo's paradise" Nature Publishing Group, August 23 2006, Last accessed March 29 2009, Available at: http://www.nature.com/nature/journal/v442/n7105/full/442848a.html
• "Online video streaming archive," Nature Publishing Group, Last accessed MArch 29 2009, Available at: http://www.nature.com/nature/videoarchive/index.html
• Suber, Peter, "Springer on the block," Open Access News March 27 2009, Last accessed March 29 2009, Available at: http://www.nature.com/nature/videoarchive/index.html
• "Cutting-Edge Resources," Springer, Last accessed March 29 2009, Available at: http://www.springer.com/references?SGWID=0-151102-12-358799-0
• "Welcome to SpringerLink!", Springer, Last accessed March 29 2009, Available at: http://www.springerlink.com/home/main.mpx
• "Springer Open Choice", Springer, Last accessed March 29 2009, Available at: http://www.springer.com/open+choice?SGWID=0-40359-0-0-0
• Albanese, Andrew, "Springer Acquires BioMed Central", Library Journal, November 1 2008, Last accessed March 29 2009, Available at: http://www.libraryjournal.com/index.asp?layout=talkbackCommentsFull&talk_back_header_id=6562538&articleid=CA6606529
• Suber, Peter, "Springer's first US deal in which subscriptions cover publication fees for affiliated authors," Open Access News, January 21 2009, Last accessed March 29 2009, http://www.earlham.edu/~peters/fos/2009/01/springer-first-us-deal-in-which.html
• "Springer and Open Access," Springer, November 7 2008, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=13036&L=0
• "Springer and other publishers extend commitment to developing world", July 10 2007, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=291&backPID=11954&L=0&tx_tnc_news=3499&cHash=604b37401f
• "Springer Statement on the Debate on the NIH’s Public Access Policy," September 14 2007, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=291&backPID=11954&L=0&tx_tnc_news=3665&cHash=0c955b5ca7
• Suber, Peter, "Springer buys BioMed Central," Open Access News, October 7 2008, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=291&backPID=11954&L=0&tx_tnc_news=3665&cHash=0c955b5ca7
• "BioMed Central," BioMed Central, Last accessed March 29 2009, Available at: http://www.biomedcentral.com/
• "BioMed Central Databases," BioMed Central, Last accessed March 29 2009, Available at: http://databases.biomedcentral.com/

Last accessed March 29 2009, Available at: http://databases.biomedcentral.com/

• "Starting an independent, open access journal," BioMed Central, Last accessed March 29 2009, Available at: http://www.biomedcentral.com/independent/starting

• Amgen, "Acquisition History", 200. Available at: http://www.amgen.com/about/acquisitions.html
• Pharmaceutical Business Review, "Amgen Inc." http://www.pharmaceutical-business-review.com/companyprofile.asp?guid=8632C7AC-1633-4198-8551-BB79570C668D
• Funding Universe, "Amgen, Inc.", http://www.fundinguniverse.com/company-histories/Amgen-Inc-Company-History.html
• Zhang, Lei, et. al., "Constructing Stack Tables with Magic %GluePlus (Another User-Defined Macro for Creating Stack Tables)" Scientific Commons, http://en.scientificcommons.org/40666678
• The Free Library, "Axys - Amgen Collaboration Determines the X-Ray Crystal Structure of Human Erythropoietin-Receptor Complex." http://www.thefreelibrary.com/Axys+-+Amgen+Collaboration+Determines+the+X-Ray+Crystal+Structure+of...-a053047665
• Brigham and Women's Hospital, "Press Release - Oct 24, 2006," October 24 2006, http://www.brighamandwomens.org/Pressreleases/PressRelease.aspx?PageID=201
• Amgen, "Amgen's Policy on Sharing Our Clinical Trial Results" May 31, 2007, http://switch.atdmt.com/action/deicrm_N53107Policy_6
• Scientific Commons, "Genentech Inc," http://en.scientificcommons.org/genentech_inc
• Atkins, Simon, "Apple Releases Apple/Genentech BLAST, Significantly Accelerating Protein and DNA Searches For The Biomedical Community" Apple Inc., February 7 2002, http://www.apple.com/ca/press/2002/02/genentech.html
• Scheller, Richard, "Our Research Vision: Home," Genentech, http://www.gene.com/gene/research/researchvision.html
• Wikipedia, "Hoffman-La Rouche," http://en.wikipedia.org/wiki/Hoffmann-La_Roche
• McCracken, Joe, "A Novel Approach Towards Sales and Research," e-corner, November 30 2006 http://ecorner.stanford.edu/authorMaterialInfo.html?mid=1614
• McCracken, Joe, "Genentech's Business Model," e-corner, November 30 2006 http://ecorner.stanford.edu/authorMaterialInfo.html?mid=1613
• Genentech, "Immunology Clinical Fellowship" http://www.gene.com/gene/pipeline/fellowship/
• Genentech, "Research Contracts and Reagents Program," http://www.gene.com/gene/reagents-program/reagents-program.jsp
• Genentech, "Press Releases: Thursday, Dec 20, 2007" December 20 2007 http://www.gene.com/gene/news/press-releases/press_statements/ps_122007.html
• Genentech, "Scientific Resource Board," http://www.gene.com/gene/research/resourceboard/
• Ramsey, Doug, "UC San Diego, Genentech scientists develop potentially disruptive antibody sequencing technology," UC Newsroom, December 18, 2008, http://www.universityofcalifornia.edu/news/article/19205
• Genentech Foundation, "Focus Areas," 2006. http://www.genentechfoundation.com/about_focus.html
• Ravven, Wallace, "New UCSF Mission Bay campus: country’s largest biomedical university expansion," University of California, San Francisco, July 22, 2003, http://news.ucsf.edu/releases/new-ucsf-mission-bay-campus-countrys-largest-biomedical-university-expansio/
• Science Blog, "Rockefeller University researchers discover immune-cell mechanism that boosts therapeutic antibody potency," 2000, http://www.scienceblog.com/community/older/2000/D/200003674.html
• Genzyme, "Fabry Community" http://www.fabrycommunity.com/global/fc_p_hp_homepage.asp
• Genzyme, "Genzyme Websites" http://www.genzyme.com/home/global_sites.asp
• Genzyme, "Gaucher Registry," https://www.lsdregistry.net/gaucherregistry/
• Genzyme, "Clinical Research" http://www.genzymeclinicalresearch.com/
• Genzyme, "Our Research: Patents and Literature" http://www.genzyme.com/research/patents/pat_home.asp
• Genzyme, "Community: Grant Applications," http://www.genzyme.com/commitment/community/grant_application.asp
• Genzyme, "Genzyme to Build New R&D Center in Beijing," April 22, 2008, http://www.genzyme.com/corp/media/GENZ%20PR-042208.asp
• Gilead Sciences, "Corporate Fact Sheet," http://www.gilead.com/corporate_fact_sheet
• Gilead Sciences, "Gilead HIV Clinical Cooperation Grant," http://www.gilead-grant.de/disclaimer.html
• Tucker, Valerie, "Gilead Sciences and Gladstone to Collaborate on HIV Targets" University of California, San Francisco, January 10 2008, http://today.ucsf.edu/stories/gilead-sciences-and-gladstone-to-collaborate-on-hiv-targets/
• Gilead Sciences, "Access in the Developing World," http://www.gilead.com/access_developing_world
• Gilead Sciences, "Gilead Foundation," http://www.gilead.com/Gilead_Foundation
• Biogen Idec, "Community Relations," http://www.biogenidec.com/site/community-relations.html
• Fox Business, "Biogen Idec to Present at the 4th Annual Citi Biotech Day," March 30, 2009, http://www.foxbusiness.com/story/markets/industries/health-care/biogen-idec-present-th-annual-citi-biotech-day/
• Biogen Idec, "Biogen Idec Innovation Incubator (bi3)" http://www.biogenidec.com/site/biogen-idec-innovation-incubator.html
• Cephalon, "Our Story" http://www.cephalon.com/about-us/our-story/
• Bennett, Johanna, "It's Wake-Up Time for a Drug Maker's Shares," Barron's, http://online.barrons.com/article/SB123922500386002435.html
• Kennedy, Val Brickates, "Cephalon To Apply For FDA Approval For Nuvigil For Jet Lag," Fox News, April 6, 2009, http://www.foxbusiness.com/story/markets/industries/health-care/cephalon-apply-fda-approval-nuvigil-jet-lag/
• Medical News Today, "Cephalon Announces Positive Results From A Phase Two Study Of NUVIGIL In Bipolar Depression," March 18, 2009, http://www.medicalnewstoday.com/articles/142610.php
• Feuerstein, Adam, "What's on Lilly's Prescription Pad?" TheStreet.com, http://www.thestreet.com/story/10479877/1/whats-on-lillys-prescription-pad.html?puc=_tscrss
• Steven, Brendan, "2 Potential Pharma M&A Targets: Cephalon and Genzyme," Seeking Alpha, March 23, 2009, http://seekingalpha.com/article/127323-2-potential-pharma-m-a-targets-cephalon-and-genzyme?source=feed
• Domain-B, "Cephalon opens bid for Aussie bio-technology firm Arana," February 29 2009 http://www.domainb.com/industry/pharma/20090228_cephalon.html
• Cephalon, "Research Partnerships," http://www.cephalon.com/partners/research-partnerships/
• Cephalon, "Going Further in Research," https://cns.cephaloniss.com/
• Cephalon, "Business Collaboration," http://www.cephalon.com/partners/business-collaboration/
• Cephalon, "Our Science," http://www.cephalon.com/our-science/
• Cephalon, "Corporate Giving," http://www.cephalon.com/corporate-giving/
• B-Net, "Ambit Biosciences Announces Discovery and Development Collaboration with Cephalon, Inc. Focused on Kinase Inhibitors," http://findarticles.com/p/articles/mi_m0EIN/is_2006_Nov_6/ai_n16820350/?tag=content-inner;col1
• PR Newswire, "Abbott Laboratories and Cephalon Sign Collaboration Agreement for Gabitril(R) (Tiagabine Hydrochloride) in the United States" June 10 1999, http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-10-1999/0000960938&EDATE=
• MedImmune, "Company Overview," http://www.medimmune.com/about/index.asp
• MedImmune, "Drug Development," http://www.medimmune.com/pipeline/technology/index.asp
• Pollack, Andrew, "Five Days; Biotech Deal," New York Times, Apri 28 2007, http://query.nytimes.com/gst/fullpage.html?res=9505E1D7123EF93BA15757C0A9619C8B63
• Associated Press, "Panel Endorses Flu Vaccine In a Spray for Young Children," October 25 2007, http://query.nytimes.com/gst/fullpage.html?res=9907EEDF1230F936A15753C1A9619C8B63
• Murret, Patricia, "Big Gaithersburg biotech gets a boost," Gazette.net, December 24 2008, http://www.gazette.net/stories/12242008/poolnew194630_32483.shtml
• MedImmune, "MedImmune Announces Winners of Third Annual Research Abstract Competition" November 17 2008, http://www.medimmune.com/press/fullstory.asp?reqid=1227384&yr=2008
• MedImmune, "MedImmune Grants Five New Fellowships to Help Expand Premature Infant Follow-Up Care Research," October 13 2008, http://www.medimmune.com/press/fullstory.asp?reqid=1208757&yr=2008
• MedImmune, " MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas," January 7 2008, http://www.medimmune.com/press/fullstory.asp?reqid=1092864&yr=2008
• MedImmune, "R&D Collaborations," http://www.medimmune.com/pipeline/collaborations.asp
• MedImmune, "Strategic Alliances," http://www.medimmune.com/about/company/alliances.asp
• Celgene, "Products and Services," http://www.celgene.com/products/revlimid-thamolid-home.aspx
• Celgene, "History," http://www.celgene.com/about-celgene/biopharmaceutical-company-about.aspx
• Seeking Alpha, "Celgene Breaking New Lows, But Hopefully Not Much Lower," http://seekingalpha.com/article/129142-celgene-breaking-new-lows-but-hopefully-not-much-lower?source=feed
• Weill Cornell Medical College, "Celgene Corporation and Weill Cornell Initiate Research Program To Evaluate the Molecular Mechanism by Which Thalidomide and IMiDs Modulate COX-2," November 20, 2001, http://news.med.cornell.edu/wcmc/wcmc_2001/11_20_01.shtml
• All Business, "Pharmacopeia achieves research milestone in Celgene collaboration." July 1 2003, http://www.allbusiness.com/technology/619727-1.html
• Laboratory Talk, "Celgene and Galapagos in target collaboration" November 23 2004, http://www.laboratorytalk.com/news/gal/gal100.html
• Access My Library "AxCell Biosciences establishes research collaboration with Celgene Corp." January 21 2003, http://www.accessmylibrary.com/coms2/summary_0286-22393688_ITM
• LinkedIn "Abraxis BioSciences" http://www.linkedin.com/companies/abraxis-bioscience
• Abraxis BioSciences, "About," http://www.abraxisbio.com/about.htm
• Abraxis BioSciences, "Abraxis BioScience Announces Plan to Separate Into Two Independent Public Companies," http://phx.corporate-ir.net/phoenix.zhtml?c=217234&p=irol-newsArticle&ID=1125657&highlight=
• Business Wire, "Abraxis BioScience Announces Plan to Create Abraxis Health, a New Enterprise Focused on Biomarkers and Personalized Medicine," January 29 2009 http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20090120005380&newsLang=en
• Abraxis BioSciences, "Publications," http://www.abraxisbio.com/rnd_publications.htm
• Marcus, Jennifer, "UCLA’s California NanoSystems Institute Partners With Abraxis BioScience to Develop New Nanobiotechnologies," UCLA Newsroom, July 26 2007, http://newsroom.ucla.edu/portal/ucla/UCLA-s-California-NanoSystems-Institute-8110.aspx
• National Comprehensive Cancer Network, "NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies" October 7 2008, www.nccn.org/about/news/pdf/AO990-266534.pdf (pdf)
• Hoovers, "ImXlone Systems Incorporated," http://www.hoovers.com/imclone/--ID__15468--/free-co-factsheet.xhtml
• FDA, "Erbitux," http://www.fda.gov/CDER/Drug/infopage/erbitux/default.htm
• ImClone Systems, "Company Overview," http://www.imclone.com/overview.php
• ImClone Systems, "Imclone Grant Office," https://www.imclonegrantoffice.com/

Unused Resources

• http://www.frost.com/prod/servlet/cpo/9452439
• http://www.gov.mb.ca/ctt/profiles/biotech/
• http://premium.hoovers.com/subscribe/ind/fr/profile/basic.xhtml?ID=174
• http://www.firstresearch.com/Industry-Research/Biotechnology-Sector.html
• http://www.accessmylibrary.com/comsite5/bin/aml2006_library_auth_tt.pl?item_id=0286-36701821
• interesting small article with sales: http://seekingalpha.com/article/79278-biotech-sector-continues-to-outperform

Biotech Business - April 2009 By: Worldwide Videotex BIOTECH BUSINESS provides detailed information on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies  |  more...

• MarketWatch: Biotechnology By: Datamonitor Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the  |  more... Search inside this report
• Biotechnology Sector By: First Research, Inc. The US biotechnology industry includes about 1,000 companies, with combined annual revenue close to $50 billion. Large companies include Amgen, Monsanto, Genentech, Applera, Genzyme, and Biogen. Because many drugs are now developed using biotechnology, the  |  more... Search inside this report
• Global Biotechnology By: IBISWorld Industry Market Research Synopsis This Industry Market Research report from IBISWorld provides a detailed analysis of the Global Biotechnology industry, including key growth trends, statistics, forecasts, the competitive environment including market shares and the key issues  |  more... Search inside this report
• Stem Cell Research Products: Opportunities, Tools & Technologies By: BioInformant Executive Summary: BIO-Informant’s latest market report, "Stem Cell Research Products: Opportunities, Tools & Technologies" was produced using a detailed end-user survey of research scientists, in which over 400 stem cell researchers from the U.S.,  |  more...
• Key Genetic Technologies Market Research Bundle (SNPs, Gene Expression Profiling, DNA Sequencing and Analytical Chips) By: Kalorama Information Genetic Technology is one of the closest-watched areas in healthcare and in the past two years Kalorama Information has published major studies on different aspects of this market. This Kalorama Information Bundle consists of  |  more... Search inside this report
• 2009 U.S. Biological Product Manufacturing Industry Report By: Barnes Reports The U.S. Biological Product Manufacturing Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2009 current and 2010 forecast estimates on the size of the  |  more...
• Insights into Platform Technology and Early-Stage Pipeline Mergers and Acquisitions By: Decision Resources Introduction The continuing activity in mergers and acquisitions (M&As) involving biotechnology companies refl ects the industry’s growth and maturity. Biotech companies are increasingly merging for strategic reasons that include business, clinical, and technological considerations. In  |  more...
• The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery By: Business Insights The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery Report Overview Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large  |  more... Search inside this report
• Scientific Research & Development in the US - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research & Development in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise,  |  more... Search inside this report
• The 2009-2014 World Outlook for Proteomics By: Icon Group International, Inc. This econometric study covers the world outlook for proteomics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question  |  more... Search inside this report
• The 2009-2014 Outlook for Proteomics in the United States By: Icon Group International, Inc. This econometric study covers the latent demand outlook for proteomics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given  |  more... Search inside this report
• Proteomics By: Global Industry Analysts This report analyzes the worldwide markets for Proteomics in Millions of US$. The major Product segments analyzed are Expression Proteomics, Functional Proteomics, and Structural Proteomics.The report provides separate comprehensive analytics for the US, Canada, Japan,  |  more...

Navigation

IP Profile of Biggest for-profit companies in BGP
Biotechnology_-_Genomic_and_Proteomics